PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay

PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay

Abstract Background Programmed death ligand 1 (PD-L1) has shown potential as a therapeutic target in numerous solid tumors. Its prognostic significance has also been established in pancreatic ductal adenocarcinoma (PDAC). The present study aimed to explore PD-L1 expression in PDAC cases in a large C...

Full description

Bibliographic Details
Main Authors: Xiaolong Liang, Jian Sun, Huanwen Wu, Yufeng Luo, Lili Wang, Junliang Lu, Zhiwen Zhang, Junchao Guo, Zhiyong Liang, Tonghua Liu
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Diagnostic Pathology
Subjects:
Pancreatic
PD-L1
Immunohistochemistry
Prognosis
Online Access:http://link.springer.com/article/10.1186/s13000-017-0678-4

Internet

http://link.springer.com/article/10.1186/s13000-017-0678-4

Similar Items